Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51.
Kurtz, David M
Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51. [electronic resource] - Leukemia & lymphoma Jul 2007 - 1290-8 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
1042-8194
10.1080/10428190701355028 doi
Adult
Aged
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Interleukin-4--administration & dosage
Lymphoma, Non-Hodgkin--complications
Male
Middle Aged
Recurrence
Salvage Therapy--methods
Survival Analysis
Treatment Outcome
Subcutaneous interleukin-4 (IL-4) for relapsed and resistant non-Hodgkin lymphoma: a phase II trial in the North Central Cancer Treatment Group, NCCTG 91-78-51. [electronic resource] - Leukemia & lymphoma Jul 2007 - 1290-8 p. digital
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, N.I.H., Extramural
1042-8194
10.1080/10428190701355028 doi
Adult
Aged
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Interleukin-4--administration & dosage
Lymphoma, Non-Hodgkin--complications
Male
Middle Aged
Recurrence
Salvage Therapy--methods
Survival Analysis
Treatment Outcome